![Gian Reverberi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gian Reverberi
Directeur/Membre du Conseil chez
SYNCONA LIMITED
Fortune : 67 937 $ au 31/05/2026
Profil
Gian Piero Reverberi is currently an Independent Non-Executive Director at Syncona Ltd. since 2018 and Senior VP & Head-Global Gastroenterology at Ferring Pharmaceuticals.
Former roles include Chairman & Managing Director at Shire France SAS, Director-Diabetes Care Business at Eli Lilly Italia SpA, District Manager at Eli Lilly & Co. from 1999 to 2004, Chief Commercial Officer & Senior Vice President at Vanda Pharmaceuticals, Inc. from 2015 to 2020, Senior VP-International Specialty Pharma at Shire Pharmaceuticals, Inc. from 2006 to 2014, and General Manager at Shire Italia SpA from 2004 to 2006.
Education includes an undergraduate degree from Sapienza University of Rome in 1988 and an MBA from SDA Bocconi School of Management in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYNCONA LTD GBP 0,01 % | 31/03/2025 | 50 000 ( 0,01 % ) | 67 937 $ | 31/05/2026 |
Postes actifs de Gian Reverberi
| Sociétés | Poste | Début |
|---|---|---|
| SYNCONA LIMITED | Directeur/Membre du Conseil | 01/04/2018 |
Anciens postes connus de Gian Reverberi
| Sociétés | Poste | Fin |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Corporate Officer/Principal | 16/03/2020 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/03/2014 |
Shire Italia SpA
 Shire Italia SpA Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 01/06/2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/05/2004 |
Eli Lilly Italia SpA
 Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formation de Gian Reverberi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Sapienza University of Rome
 Sapienza University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Shire Italia SpA
Shire Italia SpA Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Eli Lilly Italia SpA
Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Shire France SAS
 Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SDA Bocconi School of Management
 SDA Bocconi School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
